GE to sell HistoSonics’ soundwave therapy for liver cancer

Jul 19, 2022

ultrasound

GE Healthcare is teaming up with the developer of a non-invasive platform for destroying liver tumors with sound waves.  | Pending FDA approval, HistoSonics will use guided sonic beams to deliver vibrations into the organ without breaking the skin, causing the targeted tissue to break down and liquify.

Source: GE to sell HistoSonics’ soundwave therapy for liver cancer | FierceBiotech

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

0 of 800 max characters
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.